Actively Recruiting
Using a Special Algorithm to Reduce Repeat Gastrointestinal Bleeding and Severe Nosebleeds in Adults with Von Willebrand Disease
Led by University Hospital, Lille · Updated on 2026-05-18
66
Participants Needed
17
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating an algorithm-based multidisciplinary management approach compared to standard care to reduce the recurrence of gastrointestinal GI bleeding or severe nosebleeds epistaxis in adults with von Willebrand Disease VWD. This prospective, multicenter, randomized trial aims to investigate whether this new management strategy can lower the incidence of bleeding episodes over time. Participants are assigned to one of two groups an optimized management group or a standard care group. The optimized management includes systematic gastrointestinal and nasal endoscopic examinations, local endoscopic treatments when needed, stepwise dose escalation of von Willebrand factor VWF concentrate, and the use of antiangiogenic drugs for patients with severe GI angiodysplasia-related bleeding. The standard care group receives usual management without this structured approach. During the study, participants will be followed for up to 72 months with regular visits to monitor bleeding recurrence, hospitalizations, and treatments received. Researchers will assess the number of bleeding episodes, hospital days, blood transfusions, iron supplementation, and VWF concentrate usage. They will also measure changes in hemoglobin, serum ferritin, bleeding scores, and quality of life using a validated questionnaire. This comprehensive monitoring aims to provide detailed information on treatment impact and patient well-being throughout the trial.
CONDITIONS
Brief Title
Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease
Research Team
M
Marie Caillierez
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here